For specific Coronavirus (COVID-19) research and guidance visit the Coronavirus information hub.
Our role is to support the delivery of high-quality clinical research in Hepatology and manage participant recruitment to time and target, both for Hepatology studies which are led from Scotland, and studies led from other nations which Scottish sites are participating in. We provide support in the following areas:
- Managing the study portfolio record
- Monitoring the attainment of recruitment targets
- Providing advice on study design and feasibility
- Troubleshooting issues with poor recruitment
- Sharing information on new studies
- Identifying potential sites for studies
- Facilitating access to resource to support research, for example through Clinical Research Facility (CRF) Research Nurses.
Liver disease is the fifth most common cause of death in the UK. Research carried out in this specialty aims to detect liver disease earlier and develop and evaluate new therapies.
The Hepatology Specialty Group oversees research that deals with the diagnosis and management of patients with diseases of the liver, biliary tree, and pancreas. Topics of Hepatology research include:
- Acute and chronic liver disease including liver failure
- The impact of identifying, screening and treating viral hepatitis
- Liver fibrosis and cirrhosis
- Normal and abnormal liver metabolism
- Genetic studies including pharmacongenetics
- Treatment of portal hypertension
Patient, carer and public information
Specialty Lead: Professor John Dillon
Performance Manager: Sarah Kennedy
Administrative Support: email@example.com